An Integrated Analysis Of Gene Expression And Chromosome Copy Number In Malignant Mesothelioma
Funder
National Health and Medical Research Council
Funding Amount
$421,697.00
Summary
Mesothelioma is an aggressive, asbestos related cancer which causes more than 20,000 deaths worldwide per annum. Mesothelioma is characterised by a long latency between exposure to asbestos and development of the disease, estimated to be between 20 and 40 years. As such, the peak number of cases of mesothelioma is not expected in Australia until 2010, as asbestos use reached its peak in the 1970-80's. In 2010, deaths from mesothelioma will be more common than ovarian cancer and melanoma. This st ....Mesothelioma is an aggressive, asbestos related cancer which causes more than 20,000 deaths worldwide per annum. Mesothelioma is characterised by a long latency between exposure to asbestos and development of the disease, estimated to be between 20 and 40 years. As such, the peak number of cases of mesothelioma is not expected in Australia until 2010, as asbestos use reached its peak in the 1970-80's. In 2010, deaths from mesothelioma will be more common than ovarian cancer and melanoma. This study aims to explore the molecular defects that are involved in initiation and progression of mesothelioma. Using array comparative genomic hybridisation, a technique which allows comparison of the DNA of normal cells with that of cancer cells, we will classify chromosomal changes in the cancer cell and identify candidate genes which are involved in mesothelioma development.Read moreRead less
Career Development Fellowship_Y C Gary Lee_Translational Research On Malignant Pleural Effusion And Pleural Infection
Funder
National Health and Medical Research Council
Funding Amount
$321,489.00
Summary
My pleural research program uniquely combines a clinical and a lab research arm integrated with a tertiary clinical service. It has a strong track record in improving clinical care in pleural cancer and infection through patient-oriented research. My program has a high productivity and strong commitment to training future pleural researchers. This Fellowship will allow me to continue the upward trajectory in research publication, training of fellows, and making advances that impact patient care.
Therapeutic Targeting Of A New Growth Factor In Mesothelioma
Funder
National Health and Medical Research Council
Funding Amount
$317,775.00
Summary
Malignant mesothelioma is an aggressive and incurable cancer. This study will build on our recent data showing a protein termed FGF-9, not previously linked with mesothelioma, could significantly stimulate mesothelioma growth. This project will examine the biologic activities of FGF-9 and its receptors in mesothelioma, and the therapeutic benefits of antagonizing FGF-9 in mesothelioma in vivo.
Prevention Of Pleural Adhesion Formation By Treatment With Growth Factors
Funder
National Health and Medical Research Council
Funding Amount
$268,000.00
Summary
Damage to the lining of the chest and abdominal cavities and to cells covering the lungs and other internal organs by infection or surgery almost always results in the formation of adhesions. Adhesions are bridges of fibrous material between organs and the body wall. In the chest cavity they can prevent the effective drainage of fluids that build up during infection or after injury leading to deterioration of health and even death. In the abdominal cavity they are a major cause of intestinal obs ....Damage to the lining of the chest and abdominal cavities and to cells covering the lungs and other internal organs by infection or surgery almost always results in the formation of adhesions. Adhesions are bridges of fibrous material between organs and the body wall. In the chest cavity they can prevent the effective drainage of fluids that build up during infection or after injury leading to deterioration of health and even death. In the abdominal cavity they are a major cause of intestinal obstruction and female infertility. In Australia, adhesions affect 9,500 patients annually, accounting for 6% of all hospital readmissions at a cost of over $100 million. This project will use animal models to investigate the specific role of a growth factor called hepatocyte growth factor (HGF) on the healing of the cells lining the internal body cavity and its effect on inhibiting adhesion formation. Using genetically manipulated mice, drug delivery and gene therapy approaches, the effect of changing the levels of HGF in tissues lining the internal body cavities on repair and adhesion formation will be assessed and mechanisms of action elucidated . A better understanding of the way cells lining these cavities heal and the factors that can improve the healing process, may lead to the development of novel therapies to prevent adhesion formation, which will benefit all future patients with chest cavity infections and those who undergo thoracic and abdominal surgery.Read moreRead less
Molecular Diagnosis And Therapy Of Autoimmune Disease Using Translational And Reverse Translational Approaches
Funder
National Health and Medical Research Council
Funding Amount
$2,331,372.00
Summary
We plan to translate our recent discoveries on human gene variants and molecules produced by immune cells (follicular T cells) into effective therapies for autoimmune diseases. This will involve understanding the mechanisms by which the genes and molecules regulate immune tolerance, stratifying patients with autoimmune disease using newly identified biomarkers, trialling existing biologicals according to affected molecular pathway, and taking novel targets through to commercialisation.
I am an immunologist determining the development and function of the dendritic cell system, including its role in autoimmunity and resistance to infection.
When Prometheus Needs A Hand – How Human Amnion Epithelial Cells Resolve Fibrosis And Regenerate The Liver
Funder
National Health and Medical Research Council
Funding Amount
$530,653.00
Summary
Cirrhosis can progress to end stage disease for which transplantation provides the only hope for survival. Liver donors in Australia are scarce; the need for donor organs is increasing. Using stem cells to repair and regenerate damaged liver may provide an alternative to organ transplantation. We are studying placental stem cells that can decrease inflammation and increase progenitor cells to repair and regenerate liver. Our goal is to use these stem cells as treatment for human liver disease